乳化驱动的YTHDC1通过抑制PTPN22介导的NLRP3脱化来缓解MASLD
Feng Zhang1,2, Linghua Zeng2, Kunkun Zou2
1General Surgery Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150086, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 26, 2025
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 的进展因YTHDC的减少而恶化1. 这项研究揭示了YTHDC1抑制炎症和脂质积累,为MASLD提供了新的治疗点.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 代谢功能障碍相关的脂肪性肝病 (MASLD) 是一种普遍存在的肝病.
- 在MASLD中,YTH域含有蛋白1 (YTHDC1) 的表达减少.
- 肝细胞中YTHDC1缺乏会使饮食引起的肝脂肪积累恶化.
研究的目的:
- 调查YTHDC1在MASLD病变发生中的作用.
- 阐明在MASLD中YTHDC1调节的基础分子机制.
- 探索针对MASLD的YTHDC1的潜在治疗策略.
主要方法:
- 在MASLD患者和小鼠模型中分析YTHDC1表达.
- 调查肝细胞特异性YTHDC1淘汰对高脂肪饮食 (HFD) 诱导的肝脂肪症的影响.
- 识别参与YTHDC1降解的蛋白质,包括AARS1及其乳化活性.
- 检查YTHDC1和LDHA之间的相互作用.
- 确定YTHDC1的下游目标,如PTPN22及其对NLRP3炎症酶激活的影响.
- 在MASLD模型中评估YTHDC1向药物梅本达的治疗潜力.
主要成果:
- 在MASLD.中,YTHDC1的表达显著减少.
- 乳酸积累和AARS1-介导的乳化驱动YTHDC1的降解.
- 一个涉及YTHDC1,LDHA和乳化的积极反循环加剧了MASLD.
- YTHDC1抑制PTPN22,这通常会激活NLRP3,从而减少肝炎和脂质积累.
- 梅本达治疗通过调节YTHDC1活性来缓解MASLD.
结论:
- 通过抑制PTPN22-NLRP3炎症轴,YTHDC1在MASLD中起着保护作用.
- 通过乳化降解YTHDC1是MASLD进展的一个关键机制.
- 用梅本达等药物向YTHDC1显示出对MASLD治疗的希望.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Translesion DNA Polymerases
11.0K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
11.0K


